Growth Metrics

Emergent BioSolutions (EBS) Finished Goods (2016 - 2020)

Historic Finished Goods for Emergent BioSolutions (EBS) over the last 11 years, with Q1 2020 value amounting to $56.2 million.

  • Emergent BioSolutions' Finished Goods changed N/A to $56.2 million in Q1 2020 from the same period last year, while for Mar 2020 it was $56.2 million, marking a year-over-year change of. This contributed to the annual value of $62.3 million for FY2019, which is 2263.78% up from last year.
  • According to the latest figures from Q1 2020, Emergent BioSolutions' Finished Goods is $56.2 million.
  • Over the past 5 years, Emergent BioSolutions' Finished Goods peaked at $62.3 million during Q4 2019, and registered a low of $10.1 million during Q1 2017.
  • Moreover, its 5-year median value for Finished Goods was $27.3 million (2016), whereas its average is $33.0 million.
  • In the last 5 years, Emergent BioSolutions' Finished Goods crashed by 5887.78% in 2017 and then surged by 26508.58% in 2018.
  • Emergent BioSolutions' Finished Goods (Quarter) stood at $23.5 million in 2016, then increased by 28.12% to $30.1 million in 2017, then skyrocketed by 68.77% to $50.8 million in 2018, then increased by 22.64% to $62.3 million in 2019, then fell by 9.79% to $56.2 million in 2020.
  • Its Finished Goods stands at $56.2 million for Q1 2020, versus $62.3 million for Q4 2019 and $54.6 million for Q3 2019.